RICARDO ROMITI
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina
LIM/53 - Laboratório de Micologia, Hospital das Clínicas, Faculdade de Medicina
LIM/50 - Laboratório de Patologia das Moléstias Infecciosas, Hospital das Clínicas, Faculdade de Medicina
LIM/53 - Laboratório de Micologia, Hospital das Clínicas, Faculdade de Medicina
LIM/50 - Laboratório de Patologia das Moléstias Infecciosas, Hospital das Clínicas, Faculdade de Medicina
13 resultados
Resultados de Busca
Agora exibindo 1 - 10 de 13
conferenceObject Scalp neuropathy in dermatomyositis patients with recalcitrant scalp pruritus(2018) CIRINO, Pablo; WIPF, Angela; ROMITI, Ricardo; MCADAMS, Brian; FOSTER, Shawn; KENNEDY, William; HORDINSKY, MariaconferenceObject Discordance between patients with psoriasis and their physicians in assessing disease severity, psoriasis-related symptoms and disease control: Results from a large observational physician and patient survey(2017) GRIFFITHS, Christopher; NALDI, Luigi; AUGUSTIN, Matthias; ROMITI, Ricardo; GUEVARA-SANGINES, Esther; HOWE, Tanya; RICHARDSON, Craig; TIAN, Haijun; JO, Seong-JinconferenceObject Impact of ixekizumab treatment on scalp psoriasis: Results from the UNCOVER-2 trial(2016) REICH, Kristian; LEBWOHL, Mark; ROMITI, Ricardo; SOFEN, Howard; GOLDBLUM, Orin; KERR, Lisa; SHROM, David; DENNEHY, Ellen; LEONARDI, CraigconferenceObject Psoriasis And Mental Health Comorbidities: A Multinational Analysis Using the Global Healthcare Study on Psoriasis (GHSP)(2023) PETERSON, Hannah; KOROURI, Edwin; KINGSTON, Paige; LEE, Kathryn; HUANG, Margaret; YEE, Danielle; AGUERO, Rosario; ARTIGA, Kevin; VALENZUELA, Fernando; ROMITI, Ricardo; DIDASKALU, Johannes; EGEBERG, Alexander; OON, Hazel H.; MAUL, Julia-Tatjana; ARMSTRONG, April W.conferenceObject Comparative analysis of the in situ interleukin 23/T-helper 17 lymphocyte axis cytokine profile in IgA pemphigus, subcorneal pustular dermatosis, and pustular psoriasis(2014) SIGNORELLI, Thais Helena Dias; MARUTA, Celina Wakisaka; SANTI, Claudia Giuli; SOTTO, Mirian Nacagami; DIAS, Natasha Favoretto; ROMITI, Ricardo; AOKI, ValeriaconferenceObject Greater burden of disease in systemic eligible psoriasis patients with anxiety and/or depression: Results from a large observational physician and patient survey(2017) NALDI, Luigi; GRIFFITHS, Christopher; JO, Seong-Jin; GUEVARA-SANGINES, Esther; ROMITI, Ricardo; HOWE, Tanya; RICHARDSON, Craig; TIAN, Haijun; AUGUSTIN, Matthias- Inflammatory bowel disease among patients with psoriasis treated with ixekizumab: A presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trials(2017) REICH, Kristian; LEONARDI, Craig; LANGLEY, Richard G.; WARREN, Richard B.; BACHELEZ, Herve; ROMITI, Ricardo; OHTSUKI, Mamitaro; XU, Wen; ACHARYA, Nayan; SOLOTKIN, Kathleen; COLOMBEL, Jean-Frederic; HARDIN, Dana S.Background: Inflammatory bowel disease (IBD) occurs more frequently in patients with psoriasis. The 2 diseases have significant genetic overlap, but the pathogenesis underlying their co-occurrence is unknown. Objective: We sought to report adjudicated IBD cases (Crohn's disease [CD] and ulcerative colitis [UC]) in patients exposed to ixekizumab, a high-affinity monoclonal antibody that selectively targets interleukin-17A. Methods: Adverse events (AEs) integrated from 7 randomized controlled and uncontrolled trials were analyzed for the controlled induction period, controlled maintenance period, and all ixekizumab-treated patients. Suspected IBD cases were reviewed by blinded external experts using internationally recognized criteria (Registre Epidemiologique des Maladies de l'Appareil Digestif registry). Results: In all, 4209 patients (6480 patient-exposure years) were exposed to ixekizumab. Suspected CD (N = 12) or UC (N = 17) AEs were reported; 19 were adjudicated as definite/probable IBD (CD, N = 7, incidence rate = 1.1/1000 patient-exposure years; UC, N = 12, incidence rate = 1.9/1000 patient-exposure years). Among these, 3 occurred during induction (CD, N = 1; UC, N = 2) and 7 during maintenance (CD, N = 4; UC, N = 3). Twelve of 16 patients with reported IBD history have not had an IBD treatment- emergent AE/serious AE to date. Limitations: Clinical review (adjudication) was not prespecified. AE data collected post-hoc may have been limited by length of time from occurrence. Conclusion: From an integrated database of 7 ixekizumab psoriasis trials, CD and UC cases were uncommon
- Short anagen syndrome in a girl with curly dark hair and consanguineous parents(2012) DOCHE, Isabella; DONATI, Aline; VALENTE, Neusa Sakai; ROMITI, Ricardo; HORDINSKY, Maria K.
conferenceObject Correlation between DLQI and PASI in patients with psoriasis - a cross-sectional Global Healthcare Study on Psoriasis (GHSP)(2023) NIELSEN, Mia-Louise; MAUL, Lara Valeska; DIDASKALU, Johannes A.; VALENZUELA, Fernando; ROMITI, Ricardo; GRIFFITHS, Christopher E. M.; NOVOA, Farah; OON, Hazel H.; EGEBERG, Alexander; ARMSTRONG, April W.; MAUL, Julia-TatjanaconferenceObject PENS syndrome: Clinical spectrum and dermoscopy findings(2016) GUIMARAES, Ana Lucia; ROMITI, Ricardo; NICO, Marcello; FERREIRA, Paula